Zelos Therapeutics Inc.

Zelos Therapeutics is an emerging private biopharmaceutical development company that is commercializing breakthrough discoveries in parathyroid hormone (PTH) research. The company is developing medications for the treatment of osteoporosis, psoriasis and for enhancing engraftment following stem cell transplantation. During 2005, Zelos Therapeutics experienced a number of significant milestones. Key programs at Zelos moved quickly ahead to their next developmental stage during the year. The lead program, injectable Ostabolin-C™ for the treatment of osteoporosis, completed a series of three Phase I trials in Canada in 2004-05 and began Phase II testing at hospital and clinic sites in Canada and the USA. The second program, Ostabolin-C™ gel for topical treatment of psoriasis, began Phase I safety testing in humans this year at sites in the USA. In addition, an inhalation powder version of Ostabolin-C™ for osteoporosis is being tested in animals, in preparation for human safety testing next year. Scientific efforts in a fourth program have recently yielded exciting results in an animal cancer model, and this fourth program will also move into the clinic for human testing next year.

Contact Details: One Tower Bridge100 Front Street, Suite 1325 West Conshohocken Pennsylvania 19428 United States of America Tel: 610-717-0121 Fax: 610-825-3936 Email: info@zelostherapeutics.com WWW: www.zelostherapeutics.com/

Loading...

BioNews Results for Zelos Therapeutics Inc.:
Tarsa, Zelos advance drugs to treat osteoporosis patients	Biz Journals:  Nov 2 2009 6:16AM Matching: zelos therapeutics inc
Zelos Therapeutics Initiates Clinical Study of First US Injectable Equivalent to Forteo(R) teriparatide	Pharmacy Choice:  Oct 22 2009 2:39PM Matching: zelos therapeutics inc
Zelos Therapeutics Initiates Clinical Study of First US Injectable Equivalent to Forteo teriparatide	Pharmacy Choice:  Oct 22 2009 2:39PM Matching: zelos therapeutics inc
Zelos Therapeutics Initiates Clinical Study Of First US Injectable Equivalent To Forteo(R) (teriparatide)	Medical News Today:  Oct 9 2009 9:41AM Matching: zelos therapeutics inc
Zelos Therapeutics Initiates Clinical Study of First US Injectable Equivalent to Forteo ...	PipelineReview:  Oct 8 2009 10:34PM Matching: zelos therapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Zelos Therapeutics Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 390 times since April 2007, the link to the organisation's website has been followed 68 times

Recent Search Terms used to find this page: zelos therapeutics ostabolin | zelos therapeutics | zelos canad | zelos therapeutics | Zelos Therapeutics Inc | Zelos Therapeutics Inc | zelos canada | zelos canada | zelos therapeutics | zelos therapeutics fax number | .

Search for more companies in West Conshohocken

Search for more companies in Pennsylvania

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Zelos Therapeutics Inc.